Sionna Therapeutics, Inc.
SION
$42.18
-$0.59-1.38%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -26.78M | -20.44M | -20.28M | -18.07M | -16.48M |
| Total Depreciation and Amortization | 154.00K | 152.00K | 189.00K | 147.00K | 159.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 6.84M | 3.96M | 2.96M | 2.16M | 1.89M |
| Change in Net Operating Assets | -2.06M | -302.00K | 1.90M | -2.40M | -1.85M |
| Cash from Operations | -21.84M | -16.63M | -15.23M | -18.15M | -16.29M |
| Capital Expenditure | -- | -204.00K | -87.00K | 0.00 | -86.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 24.82M | 22.79M | 23.19M | -23.25M | -141.11M |
| Cash from Investing | 24.82M | 22.59M | 23.10M | -23.25M | -141.19M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2.21M | 1.66M | 1.97M | -- | 202.39M |
| Repurchase of Common Stock | -- | -- | -- | -312.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -320.00K | -- | -- | -- | -- |
| Cash from Financing | 1.89M | 1.66M | 1.97M | -312.00K | 202.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.87M | 7.62M | 9.85M | -41.71M | 44.91M |